Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study.

Elife · 2023 · PMC10627511 · PMID 37929934

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Further comparative analysis of baseline ctDNA parameters in different treatment response groups revealed that TMB was progressively lower across the four groups, showing a decreasing trend from the PD group to the CR group.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.